Research
Experimental cell therapy improves skin resilience, advancing treatments for skin injuries
The Brief
- In a phase 1 clinical trial, Johns Hopkins Medicine researchers partially transformed ordinary human skin cells into volar skin.
- Volar skin is the durable skin found only on the palms and soles, which resists friction and pressure.
- The reported work is an experimental cell therapy aimed at improving skin resilience and treating skin injuries.
Why it matters
It shows that ordinary skin cells can be partly reprogrammed toward a more friction- and pressure-resistant skin type, a possible route to treatments for skin injuries.
Who’s affected
- clinicians and researchers in regenerative medicine
- people with chronic skin injuries or pressure-related wounds
- #cell therapy
- #regenerative medicine
- #skin injury
- #clinical trial
- #wound care
In a phase 1 clinical trial, Johns Hopkins Medicine researchers say they have partially transformed ordinary human skin cells into volar skin—the durable skin found exclusively on the palms and soles that resists friction and pressure.
Timeline
Johns Hopkins researchers report partial transformation of skin cells into volar skin in a phase 1 trial
Medical Xpress - latest medical and health news stories
Experimental cell therapy improves skin resilience, advancing treatments for skin injuries